Korean Drug Co Ltd
KOSDAQ:014570
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Korean Drug Co Ltd
Total Assets
Korean Drug Co Ltd
Total Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
K
|
Korean Drug Co Ltd
KOSDAQ:014570
|
Total Assets
₩94.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
|
Yuhan Corp
KRX:000100
|
Total Assets
₩3.2T
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Total Assets
₩1.2T
|
CAGR 3-Years
22%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Total Assets
₩2.1T
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
2%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Total Assets
₩561.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
12%
|
CAGR 10-Years
12%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Total Assets
₩231.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Korean Drug Co Ltd
Glance View
KOREAN DRUG Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. The company is headquartered in Icheon, Gyeonggi-Do and currently employs 256 full-time employees. The company went IPO on 2000-12-07. The Company’s products portfolio consists of over-the-counter (OTC) medicines, ethical (ETC) medicines and health food, including multi-symptom cold medicines, blood-forming nutrients, treatments for central nervous system, remedies for respiratory diseases, dermatological agents, vitamins, antifungal agents, antipyretics, analgesics, anti-inflammatory drugs, antibiotics, allergic treatments, calcium and vitamin D tablets and home pregnancy test kits, among others.
See Also
What is Korean Drug Co Ltd's Total Assets?
Total Assets
94.3B
KRW
Based on the financial report for Dec 31, 2025, Korean Drug Co Ltd's Total Assets amounts to 94.3B KRW.
What is Korean Drug Co Ltd's Total Assets growth rate?
Total Assets CAGR 10Y
5%
Over the last year, the Total Assets growth was 6%.
